ENTRY       mmu05213                    Pathway
NAME        Endometrial cancer - Mus musculus (mouse)
DESCRIPTION Endometrial cancer (EC) is the most common gynaecological malignancy and the fourth most common malignancy in women in the developed world after breast, colorectal and lung cancer. Two types of endometrial carcinoma are distinguished with respect to biology and clinical course. Type-I carcinoma is related to hyperestrogenism by association with endometrial hyperplasia, frequent expression of estrogen and progesterone receptors and younger age, whereas type-II carcinoma is unrelated to estrogen, associated with atrophic endometrium, frequent lack of estrogen and progesterone receptors and older age. The morphologic differences in these cancers are mirrored in their molecular genetic profile with type I showing defects in DNA-mismatch repair and mutations in PTEN, K-ras, and beta-catenin, and type II showing aneuploidy, p53 mutations, and her2/neu amplification.
CLASS       Human Diseases; Cancer: specific types
PATHWAY_MAP mmu05213  Endometrial cancer
ORGANISM    Mus musculus (mouse) [GN:mmu]
GENE        13645  Egf; epidermal growth factor [KO:K04357]
            13649  Egfr; epidermal growth factor receptor [KO:K04361] [EC:2.7.10.1]
            18706  Pik3ca; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]
            18707  Pik3cd; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]
            74769  Pik3cb; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]
            18709  Pik3r2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]
            18708  Pik3r1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]
            18710  Pik3r3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]
            19211  Pten; phosphatase and tensin homolog [KO:K01110] [EC:3.1.3.16 3.1.3.48 3.1.3.67]
            18607  Pdpk1; 3-phosphoinositide dependent protein kinase 1 [KO:K06276] [EC:2.7.11.1]
            16202  Ilk; integrin linked kinase [KO:K06272] [EC:2.7.11.1]
            11651  Akt1; thymoma viral proto-oncogene 1 [KO:K04456] [EC:2.7.11.1]
            11652  Akt2; thymoma viral proto-oncogene 2 [KO:K04456] [EC:2.7.11.1]
            23797  Akt3; thymoma viral proto-oncogene 3 [KO:K04456] [EC:2.7.11.1]
            12371  Casp9; caspase 9 [KO:K04399] [EC:3.4.22.62]
            12015  Bad; BCL2-associated agonist of cell death [KO:K02158]
            56484  Foxo3; forkhead box O3 [KO:K09408]
            14784  Grb2; growth factor receptor bound protein 2 [KO:K04364]
            20662  Sos1; SOS Ras/Rac guanine nucleotide exchange factor 1 [KO:K03099]
            20663  Sos2; SOS Ras/Rho guanine nucleotide exchange factor 2 [KO:K03099]
            15461  Hras; Harvey rat sarcoma virus oncogene [KO:K02833]
            16653  Kras; Kirsten rat sarcoma viral oncogene homolog [KO:K07827]
            18176  Nras; neuroblastoma ras oncogene [KO:K07828]
            11836  Araf; Araf proto-oncogene, serine/threonine kinase [KO:K08845] [EC:2.7.11.1]
            109880  Braf; Braf transforming gene [KO:K04365] [EC:2.7.11.1]
            110157  Raf1; v-raf-leukemia viral oncogene 1 [KO:K04366] [EC:2.7.11.1]
            26395  Map2k1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]
            26396  Map2k2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]
            26413  Mapk1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
            26417  Mapk3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]
            13712  Elk1; ELK1, member of ETS oncogene family [KO:K04375]
            17350  Mlh1; mutL homolog 1 [KO:K08734]
            12550  Cdh1; cadherin 1 [KO:K05689]
            12387  Ctnnb1; catenin (cadherin associated protein), beta 1 [KO:K02105]
            12386  Ctnna2; catenin (cadherin associated protein), alpha 2 [KO:K05691]
            216033  Ctnna3; catenin (cadherin associated protein), alpha 3 [KO:K05691]
            12385  Ctnna1; catenin (cadherin associated protein), alpha 1 [KO:K05691]
            12005  Axin1; axin 1 [KO:K02157]
            12006  Axin2; axin 2 [KO:K04385]
            11789  Apc; APC, WNT signaling pathway regulator [KO:K02085]
            23805  Apc2; APC regulator of WNT signaling pathway 2 [KO:K02085]
            56637  Gsk3b; glycogen synthase kinase 3 beta [KO:K03083] [EC:2.7.11.26]
            21414  Tcf7; transcription factor 7, T cell specific [KO:K02620]
            21415  Tcf7l1; transcription factor 7 like 1 (T cell specific, HMG box) [KO:K04490]
            21416  Tcf7l2; transcription factor 7 like 2, T cell specific, HMG box [KO:K04491]
            16842  Lef1; lymphoid enhancer binding factor 1 [KO:K04492]
            17869  Myc; myelocytomatosis oncogene [KO:K04377]
            12443  Ccnd1; cyclin D1 [KO:K04503]
            22059  Trp53; transformation related protein 53 [KO:K04451]
            12575  Cdkn1a; cyclin-dependent kinase inhibitor 1A (P21) [KO:K06625]
            13197  Gadd45a; growth arrest and DNA-damage-inducible 45 alpha [KO:K04402]
            17873  Gadd45b; growth arrest and DNA-damage-inducible 45 beta [KO:K04402]
            23882  Gadd45g; growth arrest and DNA-damage-inducible 45 gamma [KO:K04402]
            12028  Bax; BCL2-associated X protein [KO:K02159]
            12018  Bak1; BCL2-antagonist/killer 1 [KO:K14021]
            107986  Ddb2; damage specific DNA binding protein 2 [KO:K10140]
            27015  Polk; polymerase (DNA directed), kappa [KO:K03511] [EC:2.7.7.7]
            13866  Erbb2; erb-b2 receptor tyrosine kinase 2 [KO:K05083] [EC:2.7.10.1]
COMPOUND    C05981  Phosphatidylinositol-3,4,5-trisphosphate
REFERENCE   PMID:15947972
  AUTHORS   Ryan AJ, Susil B, Jobling TW, Oehler MK.
  TITLE     Endometrial cancer.
  JOURNAL   Cell Tissue Res 322:53-61 (2005)
            DOI:10.1007/s00441-005-1109-5
REFERENCE   PMID:14747944
  AUTHORS   Lax SF.
  TITLE     Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification.
  JOURNAL   Virchows Arch 444:213-23 (2004)
            DOI:10.1007/s00428-003-0947-3
REFERENCE   PMID:16508724
  AUTHORS   Shiozawa T, Konishi I.
  TITLE     Early endometrial carcinoma: clinicopathology, hormonal aspects, molecular genetics, diagnosis, and treatment.
  JOURNAL   Int J Clin Oncol 11:13-21 (2006)
            DOI:10.1007/s10147-005-0546-1
REFERENCE   PMID:17028294
  AUTHORS   Hecht JL, Mutter GL.
  TITLE     Molecular and pathologic aspects of endometrial carcinogenesis.
  JOURNAL   J Clin Oncol 24:4783-91 (2006)
            DOI:10.1200/JCO.2006.06.7173
REFERENCE   PMID:11431710
  AUTHORS   Matias-Guiu X, Catasus L, Bussaglia E, Lagarda H, Garcia A, Pons C, Munoz J, Arguelles R, Machin P, Prat J.
  TITLE     Molecular pathology of endometrial hyperplasia and carcinoma.
  JOURNAL   Hum Pathol 32:569-77 (2001)
            DOI:10.1053/hupa.2001.25929
REFERENCE   PMID:15284264
  AUTHORS   Slomovitz BM, Broaddus RR, Burke TW, Sneige N, Soliman PT, Wu W, Sun CC, Munsell MF, Gershenson DM, Lu KH.
  TITLE     Her-2/neu overexpression and amplification in uterine papillary serous carcinoma.
  JOURNAL   J Clin Oncol 22:3126-32 (2004)
            DOI:10.1200/JCO.2004.11.154
REFERENCE   PMID:7585656
  AUTHORS   Saffari B, Jones LA, el-Naggar A, Felix JC, George J, Press MF.
  TITLE     Amplification and overexpression of HER-2/neu (c-erbB2) in endometrial cancers: correlation with overall survival.
  JOURNAL   Cancer Res 55:5693-8 (1995)
REFERENCE   PMID:16248975
  AUTHORS   Kim D, Chung J.
  TITLE     Akt: versatile mediator of cell survival and beyond.
  JOURNAL   J Biochem Mol Biol 35:106-15 (2002)
            DOI:10.5483/bmbrep.2002.35.1.106
REL_PATHWAY mmu04010  MAPK signaling pathway
            mmu04012  ErbB signaling pathway
            mmu04060  Cytokine-cytokine receptor interaction
            mmu04110  Cell cycle
            mmu04115  p53 signaling pathway
            mmu04151  PI3K-Akt signaling pathway
            mmu04310  Wnt signaling pathway
            mmu04520  Adherens junction
KO_PATHWAY  ko05213
///
